E A De Bruijn - JoVE Visualize

Showing results (11-20 of 85) with videos related to

Pageof 9

Sort By:

Journal of Chromatography|March 8, 1991

Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin CG Pattyn, A T van Oosterom, E A de Bruijn, et al.

British Journal of Clinical Pharmacology|June 1, 1996

Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulationJ R Soedirman, E A De Bruijn, R A Maes, et al.

Clinical Pharmacokinetics|August 19, 1999

Intravesical drug delivery. Pharmacokinetic and clinical considerationsM S Highley, A T van Oosterom, R A Maes, et al.

Pharmacy World & Science : PWS|February 11, 1999

Angiogenesis: possibilities for therapeutic interventionsW Wynendaele, A T van Oosterom, A Pawinski, et al.

Japanese Journal of Cancer Research : Gann|October 1, 1992

Fluorouracil catabolism in the combination treatment of cyclophosphamide, methotrexate and fluorouracilE A De Bruijn, S A Van der Heyden, E E Gheuens, et al.

Biological Mass Spectrometry|March 1, 1994

The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometryG Momerency, K Van Cauwenberghe, P H Slee, et al.

Urological Research|January 1, 1995

Effects and systemic uptake of the new mitomycin C analogue KW-2149 in beagle dogs after intravesical administrationM Sorber, E A De Bruijn, M Kockx, et al.

Anticancer Research|July 1, 1983

Pharmacokinetics of the cytostatic drugs used in the CMF-regimenP H Slee, E A de Bruijn, O M Driessen, et al.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 20, 1999

[Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer]P Scalliet, C De Pooter, P W Hellemans, et al.

Critical Reviews in Clinical Laboratory Sciences|April 9, 1998

In vivo model systems in P-glycoprotein-mediated multidrug resistanceW van de Vrie, R L Marquet, G Stoter, et al.

Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:

Pageof 9

Journal of Chromatography|March 8, 1991

Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin CG Pattyn, A T van Oosterom, E A de Bruijn, et al.

British Journal of Clinical Pharmacology|June 1, 1996

Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulationJ R Soedirman, E A De Bruijn, R A Maes, et al.

Clinical Pharmacokinetics|August 19, 1999

Intravesical drug delivery. Pharmacokinetic and clinical considerationsM S Highley, A T van Oosterom, R A Maes, et al.

Pharmacy World & Science : PWS|February 11, 1999

Angiogenesis: possibilities for therapeutic interventionsW Wynendaele, A T van Oosterom, A Pawinski, et al.

Japanese Journal of Cancer Research : Gann|October 1, 1992

Fluorouracil catabolism in the combination treatment of cyclophosphamide, methotrexate and fluorouracilE A De Bruijn, S A Van der Heyden, E E Gheuens, et al.

Biological Mass Spectrometry|March 1, 1994

The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometryG Momerency, K Van Cauwenberghe, P H Slee, et al.

Urological Research|January 1, 1995

Effects and systemic uptake of the new mitomycin C analogue KW-2149 in beagle dogs after intravesical administrationM Sorber, E A De Bruijn, M Kockx, et al.

Anticancer Research|July 1, 1983

Pharmacokinetics of the cytostatic drugs used in the CMF-regimenP H Slee, E A de Bruijn, O M Driessen, et al.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 20, 1999

[Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer]P Scalliet, C De Pooter, P W Hellemans, et al.

Critical Reviews in Clinical Laboratory Sciences|April 9, 1998

In vivo model systems in P-glycoprotein-mediated multidrug resistanceW van de Vrie, R L Marquet, G Stoter, et al.

Pageof 9